| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/14/2013 | US20130065914 Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| 03/14/2013 | US20130065909 Fatty acid fumarate derivatives and their uses |
| 03/14/2013 | US20130065908 Dihydrofuro pyrimidines as akt protein kinase inhibitors |
| 03/14/2013 | US20130065905 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine |
| 03/14/2013 | US20130065904 Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders |
| 03/14/2013 | US20130065899 Heteroaryl compounds and uses thereof |
| 03/14/2013 | US20130065898 Use of dihydroimidazolones for the treatment of dogs |
| 03/14/2013 | US20130065895 Pyrazolopyridine, Pyrazolopyrazine, Pyrazolopyrimidine, Pyrazolothiophene and Pyrazolothiazole Compounds as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction |
| 03/14/2013 | US20130065894 6-(4-HYDROXY-PHENYL)-3-STYRYL-1H-PYRAZOLO[3,4-b]PYRIDINE-4-CARBOXYLIC ACID AMIDE DERIVATIVES AS KINASE INHIBITORS |
| 03/14/2013 | US20130065892 Heteroaryl compounds and uses thereof |
| 03/14/2013 | US20130065889 2,5-disubstituted arylsulfonamide ccr3 antagonists |
| 03/14/2013 | US20130065886 Administration of benzodiazepine compositions |
| 03/14/2013 | US20130065885 Oral therapeutic compound delivery system |
| 03/14/2013 | US20130065883 Triazolo [4, 5- B] Pyridin Derivatives |
| 03/14/2013 | US20130065882 VLA-4 inhibitory drug |
| 03/14/2013 | US20130065881 Tricyclic Compounds for Use as Kinase Inhibitors |
| 03/14/2013 | US20130065880 Compounds as tyrosine kinase modulators |
| 03/14/2013 | US20130065877 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof |
| 03/14/2013 | US20130065868 Anxioytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods |
| 03/14/2013 | US20130065863 Nitroxyl (hno) releasing compounds and uses thereof in treating diseases |
| 03/14/2013 | US20130065860 3-(4-(5-phenyl-1 ,2,4-oxadiazol-3-yl)phenoxy)propan-2-ol derivatives as sphingosine-1 phosphate receptors modulators |
| 03/14/2013 | US20130065858 Compounds useful as raf kinase inhibitors |
| 03/14/2013 | US20130065843 Phenolic Compositions Derived From Apple Skin And Uses Thereof |
| 03/14/2013 | US20130065842 COMPOUNDS AS RORyT MODULATORS AND USES THEREOF |
| 03/14/2013 | US20130065834 Modulators of proteasome activity |
| 03/14/2013 | US20130065831 Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol) |
| 03/14/2013 | US20130065830 Dopamine Neuron Stimulating Peptide-11 Protection From Complex 1 Mitochondrial Inhibitors |
| 03/14/2013 | US20130065827 Crystalline Peptide Epoxyketone Immunoproteasome Inhibitor |
| 03/14/2013 | US20130065825 Compositions and Methods for Delaying Senescence or Cell Death in Neurons |
| 03/14/2013 | US20130065816 Analogs of pituitary adenylate cyclase-activating polypeptide (pacap) and methods for their use |
| 03/14/2013 | US20130064904 Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof |
| 03/14/2013 | US20130064893 Stabilized pharmaceutical composition |
| 03/14/2013 | US20130064889 Tablet-in-tablet Palperidone Formulations and Methods for Production and Use Thereof |
| 03/14/2013 | US20130064837 Integrin alpha-v beta8 neutralizing antibody |
| 03/14/2013 | US20130064836 Compositions and Methods for Antibodies Targeting Complement Protein C5 |
| 03/14/2013 | US20130064817 Engineered anti-il-23r antibodies |
| 03/14/2013 | US20130064804 BIO-REPLENISHMENT (BioRep) FOR IMPROVING SLEEP ARCHITECTURE |
| 03/14/2013 | US20130064803 BIO-REPLENISHMENT (BioRep) FOR COGNITIVE HEALTH |
| 03/14/2013 | US20130064801 Cellular Compositions and Methods of Making and Using Them |
| 03/14/2013 | US20130064777 Surfactant-free water-free foamable compositions, breakable foams and gels their uses |
| 03/14/2013 | US20130064775 Use of riluzole for treating or preventing the adverse effects of antineoplastic agents |
| 03/14/2013 | US20130064773 Drug-containing implants and methods of use thereof |
| 03/14/2013 | US20130064760 Method for Treating Crohn's Disease By Administering An Anti-IL-12 Antibody |
| 03/14/2013 | CA2861150A1 Morphinan derivative |
| 03/14/2013 | CA2848212A1 Neuroactive steroids, compositions, and uses thereof |
| 03/14/2013 | CA2847811A1 Treatment of diseases related to alpha subunits of sodium channels, voltage-gated (scnxa) with small molecules |
| 03/14/2013 | CA2847736A1 A new polymorphic form of pridopidine hydrochloride |
| 03/14/2013 | CA2847624A1 Pharmaceutical agent for treating amyotrophic lateral sclerosis or suppressing disease progress thereof |
| 03/14/2013 | CA2847339A1 Piperazine-substituted benzothiophene derivatives as antipsychotic agents |
| 03/14/2013 | CA2846667A1 Serpinf2-binding molecules and methods of use |
| 03/14/2013 | CA2846503A1 Use of 1h-quinazoline-2,4-diones for use in the prevention or treatment of photosensitive epilepsy |
| 03/14/2013 | CA2844652A1 Pde10 modulators |
| 03/13/2013 | EP2567959A1 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| 03/13/2013 | EP2567954A1 Method for inhibiting tau protein aggregation and treatment of alzheimer's disease with a compound derived from quinoline |
| 03/13/2013 | EP2567705A2 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 03/13/2013 | EP2567699A1 Treatment of progressive neurodegenerative disease with ibudilast |
| 03/13/2013 | EP2567696A1 Compositions for treating autism spectrum disorder |
| 03/13/2013 | EP2567625A1 Preparation containing betulinic acid, obtained from a plant of the family Marcgraviaceae |
| 03/13/2013 | EP2566882A1 Agents for treating alzheimer's disease |
| 03/13/2013 | EP2566880A1 Aromatic-cationic peptides and uses of same |
| 03/13/2013 | EP2566877A1 Methods of reducing symptoms in subjects using single dosage forms with tapering release rates |
| 03/13/2013 | EP2566861A1 Modulators of fatty acid amide hydrolase |
| 03/13/2013 | EP2566856A2 Compounds and methods of treating brain disorders |
| 03/13/2013 | EP2566855A1 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds |
| 03/13/2013 | EP2566849A1 8-hydroxy-quinoline derivatives |
| 03/13/2013 | EP2566481A1 Aza-indole derivatives useful as modulators of faah |
| 03/13/2013 | EP2566476A1 Nicotine-containing pharmaceutical compositions |
| 03/13/2013 | EP2566475A2 Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration |
| 03/13/2013 | EP2407536A9 ADP-ribosyl transferase fusion variant proteins |
| 03/13/2013 | CN202777137U Medicine health-care hand pillow |
| 03/13/2013 | CN1981776B Composition containing rare ginseng saponin, its production and usage |
| 03/13/2013 | CN1578785B Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 03/13/2013 | CN102971325A Compounds for the reduction of beta-amyloid production |
| 03/13/2013 | CN102971310A (3 -methylpyrrolidin- 3 - yl) methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists |
| 03/13/2013 | CN102971307A Piperidinyl pyrimidine amides as KV7 potassium channel openers |
| 03/13/2013 | CN102971306A Pyrazolopyridines as inhibitors of the kinase LRRK2 |
| 03/13/2013 | CN102971293A Bipyridyl derivatives useful for the treatment of kinase-induced diseases |
| 03/13/2013 | CN102971291A Novel amide derivative and use thereof as medicine |
| 03/13/2013 | CN102970996A Compositions and methods for reduction of mercury toxicity |
| 03/13/2013 | CN102970987A Methods of delivering a health care active by administering personal health care articles comprising a filament |
| 03/13/2013 | CN102970982A Enteric tablet |
| 03/13/2013 | CN102964451A msCT-CTx fusion protein for treating osteoporosis and reliving pain and nucleic acid encoding fusion protein |
| 03/13/2013 | CN102964403A Gastrodin compound and medicine composition thereof |
| 03/13/2013 | CN102964361A Application of selective alpha2A receptor stimulants to treatment of Alzheimer disease |
| 03/13/2013 | CN102964349A Tosilate of benzodiazepine derivative, its crystal forms, their preparation method and application |
| 03/13/2013 | CN102964340A Selective dopamine D1 receptor stimulants for treating Alzheimer disease |
| 03/13/2013 | CN102964302A Morphinan compounds |
| 03/13/2013 | CN102964296A Fluorinated derivatives of deferiprone |
| 03/13/2013 | CN102964283A 4-thiosemicarbazide formal benzyl (amino acid) amide compound and application thereof |
| 03/13/2013 | CN102964279A Kappa-opioid receptor agonists with peripheral analgesic effect |
| 03/13/2013 | CN102964264A Preparation method of natural general alkaloids of capsicum annuum |
| 03/13/2013 | CN102964238A Bipolar trans-carotenoid salt and application thereof |
| 03/13/2013 | CN102961731A Smoking deterent |
| 03/13/2013 | CN102961726A Agentia for treating schizophrenia |
| 03/13/2013 | CN102961725A Agentia for treating dysthymia |
| 03/13/2013 | CN102961675A Traditional Chinese medicine composition for treating neurasthenia |
| 03/13/2013 | CN102961651A Compound Chinese medicinal herb liquor for drug treatment and method for preparing the same |
| 03/13/2013 | CN102961650A Compound Chinese medicinal herb capsules for drug treatment and preparation method thereof |
| 03/13/2013 | CN102961623A Chinese patent medicine for treating cardiac neurosis |
| 03/13/2013 | CN102961621A Traditional Chinese medicine preparation for treating viral cardiac neurosis |